Having an itch that you just can’t scratch is one of the most frustrating experiences – but it might actually be beneficial ...

Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

In the three aforementioned studies of epidural delivery of naloxone in combination with an opioid (fentanyl or morphine), the frequency of pruritus was decreased, with no reversal of analgesia noted.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Medically reviewed by Jay N. Yepuri, MDMedically reviewed by Jay N. Yepuri, MD Bile duct cancer, also known as ...

A collaborative study has revealed how a specific species of mammal-targeting worms found a way around itch, allowing researchers to better understand the mammalian urge to scratch.

TH104, the Company's lead candidate for moderate-to-severe pruritus in chronic liver disease, showed no opioid withdrawal ...

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented ...

A panel of dermatologists and plastic surgeons created a consensus statement on the use of intralesional corticosteroids in patients with keloids.

Tharimmune (THAR) presented new TH104 Phase 1 data at the American College of Gastroenterology 2024 Annual Scientific Meeting, underway in ...

In addition, among patients with moderate to severe pruritus at baseline, Gilead’s drug achieved a mean reduction on the numerical rating scale (HRS) of 3.1 points at two years, which the ...

TH104, the Company's lead candidate for moderate-to-severe pruritus in chronic liver disease, showed no opioid withdrawal ...